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LETTERS TO THE EDITOR
Concerning the Fontan Patient’s Excessive
Minute Ventilation during Exercise
In their recent, insightful article concerning the cardiorespiratory
response to exercise following the Fontan procedure, Troutman et al.
(1) noted that patients with Fontan physiology tend to have elevated
DVE/DVCO2 during exercise. Although these authors acknowledged
that elevated VD/VT could account for this finding, they dismissed this
explanation in favor of a conjectured low chemoreceptor setpoint for
PaCO2. They considered the Fontan patients’ low-end tidal pCO2
measurements to be supportive of this latter hypothesis. They admit-
ted, however, that the mechanism by which the setpoint is lowered is
not readily apparent, and the mechanisms they proposed were rather
unsatisfying.
In contrast, ventilation/perfusion mismatch, secondary to the pul-
monary blood flow maldistribution that undoubtedly exists in the
Fontan patient’s nonpulsatile pulmonary circulation, could plausibly
account for the low end tidal pCO2, elevated VD/VT, and elevated
DVE/DVCO2. We have recently found evidence of that maldistribution
of pulmonary blood flow secondary to pulmonary artery stenoses,
which may cause similar ventilatory abnormalities during exercise in
patients with tetralogy of Fallot (2). Furthermore, on the basis of a few
reasonable assumptions and measurements similar to those employed
in Troutman’s study, we have generated estimates of VD/VT during
exercise and found that Fontan patients have significantly higher
VD/VT than do normal subjects and patients with tetralogy of Fallot
(3). Hence, we feel that pulmonary blood flow maldistribution, sec-
ondary to the absence of a pulmonary ventricle, is at the root of the
Fontan patient’s abnormal ventilatory pattern during exercise. This
explanation is compatible with the Fontan patient’s known cardiopul-
monary pathophysiology and seems to us much more plausible than
the speculation concerning an altered chemoreceptor setpoint.
P.S. Troutman et al. refer to an abrupt increase in PETCO2 as a
criterion for the determination of the anaerobic threshold (pg. 669,
second column, last line). Clearly they meant to say “PETO2.” You may
wish to publish this correction in a future issue.
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Reply
We thank Dr. Rhodes for his input regarding our interpretation of the
gas exchange data in Fontan patients during exercise. As pointed out
in our article, the two most likely explanations for excessive ventilation
are changes in chemoreceptor setpoint for PaCO2 and an increase in
VD/VT (deadspace ventilation). We clearly did not intend to dismiss
the latter as a possibility. Intuitively, increased physiologic deadspace,
secondary to ventilation-perfusion mismatches in Fontan patients with
prior thoracic surgery and laminar pulmonary blood flow, could
contribute to our findings. We welcome Dr. Rhodes’ interest in this
area and await the opportunity to examine his data. Our experiments
did not include invasive measurements of arterial oxygenation or other
techniques, which would have allowed direct calculation of VD/VT.
Until more direct measurements are made, or until improved, nonin-
vasive methods are developed, we will be dependent on indirect data
to explain the excessive ventilation during exercise found in these very
complex and diverse patients.
Finally, we thank Dr. Rhodes for pointing out the typographical
error regarding an increase in PETO2 not PETCO2 as an indicator for
identifying the respiratory anaerobic threshold.
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Lipoprotein (a): An Important Risk Factor in
Coronary Artery Disease
In most studies, the odds of coronary artery disease (CAD) have been
modest, usually 2 to 4, when the serum lipoprotein (a) [Lp(a)] level is
above 30 to 40 mg/dL using simple univariate analysis (1). This risk
nearly doubles when LDL is also elevated, with a corresponding
decrease in risk when the elevated LDL is lowered. This observation
has led many investigators to suggest that Lp(a) itself may not be an
important risk factor in the absence of elevated LDL (2). This
erroneous conclusion seems to have been reinforced by the Canadian
study by Cantin et al (3). They recommend that Lp(a) measurement
should not be carried out in primary prevention. We disagree with
their recommendations, because measurement of Lp(a) could identify
individuals at high risk of development of CAD as well as those who
benefit most from lipid-optimizing therapy.
Although Lp(a) was not an independent risk factor in French-
Canadians, others have found Lp(a) to be a powerful independent risk
factor in Germans (4), Swedes (5), and Americans (6). In the Canadian
study, the highest odds ratio for CAD for combined elevation of Lp(a)
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